Pictura Bio aims to massively reduce the global impact of infectious diseases by making accurate, ultra rapid diagnostic tests accessible for every pathogen.
Pictura Bio is building a next-generation diagnostic platform that combines AI and a novel molecular labeling technique (PIC-ID) to rapidly detect any bacterial or viral pathogen in under a minute. By overcoming the slowness, inaccuracy, and high cost of conventional tests, Pictura Bio aims to transform point-of-care diagnostics and enable faster, more effective treatments worldwide.
Pictura Bio is an Oxford University spinout founded in 2021.
